Table 1.
Clinical and demographic characteristics of the included subjects according to the presence and severity of the pulmonary injury.
| Demographic Characteristics, Laboratory Data | COVID-19 Patients with Pulmonary Injury (2–40%) n = 53 |
COVID-19 Patients without Pulmonary Injury n = 44 |
p-Value |
|---|---|---|---|
| Age (years) | 46.01 ± 7.66 | 41.31 ± 10.49 | 0.01 |
| Gender: | |||
| Females | 30/53 (56.6%) | 30/44 (68.2%) | 0.33 |
| Males | 23/53 (43.4%) | 14/44 (31.8%) | 0.33 |
| BMI (kg/m2) | 30.66 ± 6.54 | 26.53 ± 5.41 | 0.001 |
| Results of the Initial COVID-19 Assessment | |||
| TCT pulmonary injury | 13.71% (2–40) | 0% | 0.03 |
| Initial CRP (mg/L) | 26.12 ± 15.73 | 18.63 ± 9.53 | 0.006 |
| ALT (IU/L) | 55.35 ± 41.24 | 34.95 ± 18.39 | 0.007 |
| AST(IU/L) | 44.64 ± 30.99 | 32.47 ± 11.36 | 0.015 |
| O2 saturation (%) | 96.28 ± 1.34 | 97.68 ± 3.62 | 0.07 |
| Weeks since COVID | 7 (3–10) | 8 (4–11) | 0.01 |
| Nr. of symptoms | 4 (2–6) | 2 (1–5) | ˂0.0001 |
Legend: BMI = body mass index; TCT = thorax computer tomography; C = Reactive Protein; ALT = alanine aminotransferase; AST = aspartate aminotransferase. Data are presented as number and percentage or mean ± standard deviation. Italic p-values highlight statistical significance (p < 0.05).